Stay informed with the latest litigation news. Explore now

IP Verse

Memorial Sloan Kettering Cancer Center competitive analysis

Latest publications and patents of Memorial Sloan Kettering Cancer Center New

Explore the latest publications and patents granted to Memorial Sloan Kettering Cancer Center, showcasing their recent innovations and technological advancements.

Last updated on: Sep 12, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Memorial Sloan Kettering Cancer Center

EP3217983
May 1, 2024Enhancement Of Tumor Response To Chemotherapy By Activation Of The Asmase/Ceramide Pathway Through Timed Administration Of A Short-Acting Anti-Angiogenic AgentGranted And Under Opposition
EP3686290
Aug 23, 2023Method And Kits For Identifying Of Cdk9 Inhibitors For The Treatment Of CancerGranted And Under Opposition
EP3065777
Jul 12, 2023Methods Of Use For Il-22 In The Treatment Of Gastrointestinal Graft Vs. Host DiseasePatent Maintained As Amended
EP2981607
Aug 19, 2020Effective Generation Of Tumor-Targeted T-Cells Derived From Pluripotent Stem CellsRevoked
EP2773748
Dec 25, 2019Midbrain Dopamine (Da) Neurons For EngraftmentGranted And Under Opposition
EP2482849
Jun 6, 2018Combination Immunotherapy For The Treatment Of CancerRevoked
EP2758777
Feb 7, 2018Detecting Ovarian CancerNo Opposition Filed Within Time Limit
EP2856876
Jan 31, 2018Constitutive Expression Of Costimulatory Ligands On Adoptively Transferred T LymphocytesNo Opposition Filed Within Time Limit

Latest patents of Memorial Sloan Kettering Cancer Center opposed by its competitors

Explore Memorial Sloan Kettering Cancer Center's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 18, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3217983
May 1, 2024Enhancement Of Tumor Response To Chemotherapy By Activation Of The Asmase/Ceramide Pathway Through Timed Administration Of A Short-Acting Anti-Angiogenic Agent1
EP3686290
Aug 23, 2023Method And Kits For Identifying Of Cdk9 Inhibitors For The Treatment Of Cancer1
EP3065777
Jul 12, 2023Methods Of Use For Il-22 In The Treatment Of Gastrointestinal Graft Vs. Host Disease1
EP2981607
Aug 19, 2020Effective Generation Of Tumor-Targeted T-Cells Derived From Pluripotent Stem Cells2
EP2773748
Dec 25, 2019Midbrain Dopamine (Da) Neurons For Engraftment1
EP2482849
Jun 6, 2018Combination Immunotherapy For The Treatment Of Cancer2

Latest PTAB cases involving Memorial Sloan Kettering Cancer Center New

Discover the latest PTAB cases involving Memorial Sloan Kettering Cancer Center, highlighting their recent legal challenges and patent disputes.

Top competitors of Memorial Sloan Kettering Cancer Center

Top competitors of Memorial Sloan Kettering Cancer Center based on patent oppositions.